Erratum: G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy (Nature Communications 6:6745 (2015)) doi: 10.1038/ncomms7745;G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy

Nature Communications

Volumn 6, Issue , 2015, Pages

  Hayashiji, Nozomi ^a   Yuasa, Shinsuke ^a   Miyagoe Suzuki, Yuko ^b   Hara, Mie ^a   Ito, Naoki ^b   Hashimoto, Hisayuki ^a   Kusumoto, Dai ^a   Seki, Tomohisa ^a   Tohyama, Shugo ^a   Kodaira, Masaki ^a   Kunitomi, Akira ^a   Kashimura, Shin ^a   Takei, Makoto ^a   Saito, Yuki ^a   Okata, Shinichiro ^a   Egashira, Toru ^a   Endo, Jin ^a   Sasaoka, Toshikuni ^c   Takeda, Shin'ichi ^b   Fukuda, Keiichi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; LENOGRASTIM; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR PAX7; GRANULOCYTE COLONY STIMULATING FACTOR; MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; PAX7 PROTEIN, MOUSE;

DISEASE INCIDENCE; GENETIC DIFFERENTIATION; GERM CELL; MUSCLE; REGENERATION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; EX VIVO STUDY; EXERCISE TOLERANCE; FEMALE; HAPLOINSUFFICIENCY; IMMUNOHISTOCHEMISTRY; LIFE EXTENSION; MALE; MOUSE; MOUSE MODEL; MUSCLE ATROPHY; MUSCLE EXERCISE; MUSCLE FIBER CULTURE; MUSCLE REGENERATION; MUSCLE STRENGTH; NONHUMAN; PROTEIN EXPRESSION; SKELETAL MUSCLE SATELLITE CELL; SURVIVAL; ANIMAL; CELL DIVISION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; LONGEVITY; METABOLISM; MUSCLE CELL; MUSCULAR DYSTROPHY, DUCHENNE; PATHOLOGY; PRIMARY CELL CULTURE; REGENERATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STEM CELL; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; LONGEVITY; MICE; MICE, INBRED MDX; MICE, KNOCKOUT; MUSCLE CELLS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOD PROTEIN; PAX7 TRANSCRIPTION FACTOR; PRIMARY CELL CULTURE; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84927728658     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8295     Document Type: Erratum

References (40)

1. Rocheteau, P., Gayraud-Morel, B., Siegl-Cachedenier, I., Blasco, M. A. & Tajbakhsh, S. A Subpopulation of adult skeletal muscle stem cells retains all template DNA strands after cell division. Cell 148, 112-125 (2012).
2. Troy, A. et al. Coordination of satellite cell activation and self-renewal by Par-complex-dependent asymmetric activation of p38a/b MAPK. Cell Stem Cell 11, 541-553 (2012).
3. Kawabe, Y.-i., Wang, Y. u. X., McKinnell, I. W., Bedford, M. T. & Rudnicki, M. A. Carm1 regulates Pax7 transcriptional activity through MLL1/2 recruitment during asymmetric satellite stem cell divisions. Cell Stem Cell 11, 333-345 (2012).
4. Cheung, T. H. et al. Maintenance of muscle stem-cell quiescence by microRNA-489. Nature 482, 524-528 (2012).
5. Relaix, F. & Zammit, P. S. Satellite cells are essential for skeletal muscle regeneration: The cell on the edge returns centre stage. Development. 139, 2845-2856 (2012).
6. Yuasa, S. et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat. Biotechnol. 23, 607-611 (2005).
7. Yuasa, S. et al. Zac1 is an essential transcription factor for cardiac morphogenesis. Circ. Res. 106, 1083-1091 (2010).
8. Shimoji, K. et al. G-CSF promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs. Cell Stem Cell 6, 227-237 (2010).
9. Hara, M. et al. G-CSF influences mouse skeletal muscle development and regeneration by stimulating myoblast proliferation. J. Exp. Med. 208, 715-727 (2011).
10. Stratos, I., Rotter, R., Eipel, C., Mittlmeier, T. & Vollmar, B. Granulocyte-colony stimulating factor enhances muscle proliferation and strength following skeletal muscle injury in rats. J. Appl. Physiol. 103, 1857-1863 (2007).
11. Emery, A. E. H. The muscular dystrophies. Lancet 359, 687-695 (2002).
12. Bushby, K. et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 9, 77-93 (2010).
13. Emery, A. E. H. Population frequencies of inherited neuromuscular 14. Muntoni, F., Torelli, S. & Ferlini, A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2, 731-740 (2003).
14. Hoffman, E. P. et al. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N. Engl. J. Med. 318, 1363-1368 (1988).
15. Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M. & Sweeney, H. L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl Acad. Sci. USA 90, 3710-3714 (1993).
16. Shi, X. & Garry, D. J. Muscle stem cells in development, regeneration, and disease. Genes Dev. 20, 1692-1708 (2006).
17. Olguin, H. C., Yang, Z., Tapscott, S. J. & Olwin, B. B. Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination. J. Cell Biol. 177, 769-779 (2007).
18. Bentzinger, C. F. et al. Fibronectin regulates Wnt7a Signaling and satellite cell expansion. Cell Stem Cell 12, 75-87 (2013).
19. Tanaka, K. K. et al. Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell 4, 217-225 (2009).
20. Zammit, P. S. et al. Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J. Cell Biol. 166, 347-357 (2004).
21. Yablonka-Reuveni, Z., Day, K., Vine, A. & Shefer, G. Defining the transcriptional signature of skeletal muscle stem cells. J. Anim. Sci. 86, E207-E216 (2008).
22. Siegel, A., Kuhlmann, P. & Cornelison, D. Muscle satellite cell proliferation and association: new insights from myofiber time-lapse imaging. Skelet. Muscle 1, 7 (2011).
23. Jones, N. C. et al. The p38a/b MAPK functions as a molecular switch to activate the quiescent satellite cell. J. Cell Biol. 169, 105-116 (2005).
24. Alter, J., Rozentzweig, D. & Bengal, E. Inhibition of myoblast differentiation by tumor necrosis factor a is mediated by c-Jun N-terminal kinase 1 and leukemia inhibitory factor. J. Biol. Chem. 283, 23224-23234 (2008).
25. Evans, N. P., Misyak, S. A., Robertson, J. L., Bassaganya-Riera, J. & Grange, R. W. Dysregulated intracellular signaling and inflammatory gene expression during initial disease onset in Duchenne muscular dystrophy. Am. J. Phys. Med. Rehabil. 88, 502-522 (2009).
26. Schiaffino, S. et al. Embryonic and neonatal myosin heavy chain in denervated and paralyzed rat skeletal muscle. Dev. Biol. 127, 1-11 (1988).
27. Richards, M. K., Liu, F., Iwasaki, H., Akashi, K. & Link, D. C. Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway. Blood 102, 3562-3568 (2003).
28. Hermans, M. H. A. et al. Perturbed granulopoiesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. Blood 92, 32-39 (1998).
29. Grady, R. M. et al. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90, 729-738 (1997).
30. Deconinck, A. E. et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90, 717-727 (1997).
31. Muntoni, F. & Wells, D. Genetic treatments in muscular dystrophies. Curr. Opin. Neurol. 20, 590-594 (2007).
32. Bushby, K., Muntoni, F., Urtizberea, A., Hughes, R. & Griggs, R. Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids 2-4 April 2004, Naarden, The Netherlands. Neuromuscul. Disord. 14, 526-534 (2004).
33. Drachman, D. B., Toyka, K. V. & Myer, E. Prednisone in Duchenne muscular dystrophy. Lancet 304, 1409-1412 (1974).
34. Fairclough, R., Bareja, A. & Davies, K. Progress in therapy for Duchenne muscular dystrophy. Exp. Physiol. 96, 1101-1113 (2011).
35. Ameen, V. & Robson, L. G. Experimental models of duchenne muscular dystrophy: relationship with cardiovascular disease. Open Cardiovasc. Med. J. 4, 265-277 (2010).
36. Quinlan, J. G. et al. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul. Disord. 14, 491-496 (2004).
37. Griggs, R. C. Duchenne muscular dystrophy: an important negative trial. Lancet Neurol. 9, 1038-1039 (2010).
38. Sharma, K. R., Mynhier, M. A. & Miller, R. G. Cyclosporine increases muscular force generation in Duchenne muscular dystrophy. Neurology 43, 527-532 (1993).
39. Cottler-Fox, M. H. et al. Stem cell mobilization. Hematology Am. Soc. Hematol. Educ. Program 1, 419-437 (2003).
40. Wang, Y. X., Dumont, N. A. & Rudnicki, M. A. Muscle stem cells at a glance. J. Cell. Sci. 127, 4543-4548 (2014).